Mainstream

Inovio outlines BLA submission timeline for INO-3107 and reports $68.4M cash position while advancing DNA medicine pipeline

Inovio outlines BLA submission timeline for INO-3107 and reports $68.4M cash position while advancing DNA medicine pipeline

Post ContentinoRead More

You might also be interested in reading Cathie Wood’s ARK Invest Enters Bitcoin ETF Race.

May 13, 2025
In Mainstream